Table 1.

Expression of immunoglobulin and immunoglobulin transcription factors in the tumor cells of classical and lymphocyte predominant Hodgkin disease

HRS cells of classical HDL&H cells of LPHDFollicular lymphoma
CD30 32/32 0/35 0/8 
CD20 6/32 35/35 8/8  
J-chain 4*/32 31/35 6/8 
Immunoglobulin mRNA 0/25 25/27 8/8  
Immunoglobulin protein 0/25 26/32 8/8 
Oct2-mRNA 21-153/11 6/6 4/4 
Oct2-protein 41-154/321-155 35/35 8/8 
BOB.1 8/321-155 35/35 8/8 
HRS cells of classical HDL&H cells of LPHDFollicular lymphoma
CD30 32/32 0/35 0/8 
CD20 6/32 35/35 8/8  
J-chain 4*/32 31/35 6/8 
Immunoglobulin mRNA 0/25 25/27 8/8  
Immunoglobulin protein 0/25 26/32 8/8 
Oct2-mRNA 21-153/11 6/6 4/4 
Oct2-protein 41-154/321-155 35/35 8/8 
BOB.1 8/321-155 35/35 8/8 

HRS cells indicates Hodgkin and Reed-Sternberg cells; HD, Hodgkin disease; LPHD, lymphocyte predominant Hodgkin disease; L&H cells, lymphocytic/histiocytic tumor cells of LPHD; Ig, immunoglobulin; mRNA, messenger RNA.

*

Very weak labeling.

One case with very weak signals for Igκ in some HRS cells.

Most cases showed in some or many HRS cells immunoreactivity with antibodies to IgG, Igκ, and Igλ. However, in the majority of the cases the immune reaction did not include the nuclear space of the HRS cells in contrast to the B cells and plasma cells that showed a strong nuclear space staining for one IgL chain type in all instances; in a few cases there was a nuclear space staining in some of the HRS cells.

F1-153

These cases also expressed Oct2 at the protein level.

F1-154

In only one case all HRS cells were positive.

F1-155

There were no classical HD cases in which HRS cells expressed both Oct2 and BOB.1/OBF.1.

Close Modal

or Create an Account

Close Modal
Close Modal